# Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus

> clinical trial · VERIFIED · 2026-07-15

Status: ACTIVE_NOT_RECRUITING · Sponsor: Chinese SLE Treatment And Research Group · Condition: Lupus Erythematosus, Systemic

- Company: Chinese SLE Treatment And Research Group
- Sector: Lupus Erythematosus, Systemic
- Primary source: https://clinicaltrials.gov/study/NCT07381465

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.